Elisabetta Malangone-Monaco

Real-World Injection Frequency and Cost of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

Szilárd Kiss, Elisabetta Malangone-Monaco, Kathleen Wilson et al. · Journal of Managed Care & Specialty Pharmacy · 2020 · 31 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

Association of Bariatric Surgery and National Medication Use

John M. Morton, Jaime Ponce, Elisabetta Malangone-Monaco et al. · Journal of the American College of Surgeons · 2018 · 23 citations

Agriculture, Nutrition, Surgery +11

Prescribing Patterns of Oral Antineoplastic Therapies Observed in the Treatment of Patients With Advanced Prostate Cancer Between 2012 and 2014: Results of an Oncology EMR Analysis

Elisabetta Malangone-Monaco, Kathleen A. Foley, Helen Varker et al. · Clinical Therapeutics · 2016 · 17 citations · Full text

Medicine, Oncology, Pharmacology +13

Real-world Direct Health Care Costs for Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab-containing Regimens in First-line or First-line Through Second-line Therapy

Stephen S. Johnston, Kathleen Wilson, Helen Varker et al. · Clinical Colorectal Cancer · 2017 · 13 citations · Full text

Medicine, Oncology, Pharmacoeconomics +14

Costs and Work Loss Burden of Diagnosed Opioid Abuse Among Employees on Workers Compensation or Short-term Disability

Stephen S. Johnston, A. Alexander, Elizabeth T. Masters et al. · Journal of Occupational and Environmental Medicine · 2016 · 12 citations

Business, Insurance, Occupational Health +13